Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medtronic v. Tyco

This article was originally published in The Gray Sheet

Executive Summary

Preliminary injunction prohibiting Surgical Dynamics (a division of Tyco's U.S. Surgical business) from producing, using, selling or offering to sell its Ray TFC spinal fusion cage becomes effective Aug. 30 (1"The Gray Sheet" Aug. 23, In Brief)

You may also be interested in...



Medtronic v. Tyco

California federal district court grants preliminary injunction against spinal fusion cage rival Surgical Dynamics (a division of Tyco's U.S. Surgical business) prohibiting it from selling its Ray TFC spinal implant fusion cage. Medtronic alleges that the device infringes patents for its Inter Fix threaded spinal fusion device. The injunction, which was announced Aug. 16 and reinforces an April 16 federal appeals court reversal in Medtronic's favor (1"The Gray Sheet" May 3, p. 19), is temporary pending completion of patent validity trial proceedings

New EU Filings

Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.

P&G Restores Volume Growth In Beauty, Grooming After Pricing Run

Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT012269

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel